I-Tranexamic Acid kunye ne-CAS 1197-18-8 kwisitokhwe
I-Tranexamic acid yimveliso eyenziwe kwi-lysine. Yinto esetyenziswa ngokuqhelekileyo i-agent ye-hemostatic ekusebenzeni kweklinikhi. Idlala umphumo we-hemostatic ngokuvimbela ukuchithwa kwe-fibrin. I-asidi ye-Trantranic inokubhengeza kakhulu iindawo ezibophezelayo ze-Lysine ze-fibrinogen affinity sites kwi-plasminase kunye ne-plasminogen, kwaye inqanda ukubopha i-plasminogen kunye ne-fibrin, kwaye ngaloo ndlela inqande ngamandla ukubola kwe-fibrin okubangelwa yi-plasminogen. Ukongezelela, umphumo we-antifibrinolytic we-tranatemic acid wawucace ngakumbi kubukho be-antifibrinolytic enzymes ezifana ne-macroglobulin kwi-serum.
| Izinto zovavanyo | Umgangatho ngokwe USP30 |
|
Inkcazo | 1.Umgubo wekristale omhlophe, awunavumba kwaye unencasa ekrakra |
| 2.I-soluble ngokukhululekileyo emanzini kunye ne-Acetic acid ye-glacial; kancinane kakhulu ukunyibilika kwi-ethanol; ayinyibiliki kwi-Etere | |
| 3.izinyibilikisa kwi-sodium hydroxide TS | |
|
Ukuchongwa | I-1.Impendulo ye-Nimhydrin ivelisa umbala omfusa onzulu |
| 2.imvula eyomileyo eyenziwe nge I-p-toluenesulfonic acid inyibilika phakathi kwe-265.0 ℃-266.0 ℃ | |
| Ukucaca kwesisombululo | Icacile kwaye ayinambala |
| I-chloride | ≤0.014% |
| Iintsimbi ezinzima | ≤10ppm |
| Arsenic | ≤22ppm |
| Izinto ezifumaneka lula ngekhabhoni | AKUKHO mbala uphuhlisayo |
| Cis-Isomer | ≤0.8% |
| Ilahleko ekomisweni | ≤0.5% |
| Intsalela ekutshisweni | ≤0.10% |
| Isivavanyi | ≥99.0% ye-C₈H1sNo₂ (yomisiwe) |
I-Tranexamic acid yi-synthetic derivative ye-lysine, elichiza le-antifibrinolytic kwaye lineempawu ze-hemostatic.
Ii-agent ze-Hemostatic zinefuthe elibalulekileyo ekuphumeni okubuhlungu, kwaye amayeza e-prophylactic ngaphambi kokuhlinzwa anokunciphisa ukopha kotyando.
25kgs/drum, 9tons/20'container
25kgs/bag, 20tons/20'container
I-Tranexamic Acid kunye ne-CAS 1197-18-8
I-Tranexamic Acid kunye ne-CAS 1197-18-8
